Previous close | 271.04 |
Open | 270.08 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 267.99 - 270.08 |
52-week range | 160.14 - 274.60 |
Volume | |
Avg. volume | 1,960 |
Market cap | 32.368B |
Beta (5Y monthly) | 1.56 |
PE ratio (TTM) | 0.44 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Equifax ( NYSE:EFX ) Second Quarter 2024 Results Key Financial Results Revenue: US$1.43b (up 8.6% from 2Q 2023). Net...
Symbiotic's (SYM) stronger segmental performance is likely to have boosted its top line in third-quarter fiscal 2024.
Unveiling the Financial Dynamics and Strategic Directions